1. Home
  2. BCAB vs MPTI Comparison

BCAB vs MPTI Comparison

Compare BCAB & MPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • MPTI
  • Stock Information
  • Founded
  • BCAB 2007
  • MPTI 1965
  • Country
  • BCAB United States
  • MPTI United States
  • Employees
  • BCAB N/A
  • MPTI N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • MPTI
  • Sector
  • BCAB Health Care
  • MPTI
  • Exchange
  • BCAB Nasdaq
  • MPTI Nasdaq
  • Market Cap
  • BCAB 96.2M
  • MPTI 117.1M
  • IPO Year
  • BCAB 2020
  • MPTI N/A
  • Fundamental
  • Price
  • BCAB $2.08
  • MPTI $51.94
  • Analyst Decision
  • BCAB Strong Buy
  • MPTI
  • Analyst Count
  • BCAB 2
  • MPTI 0
  • Target Price
  • BCAB $6.00
  • MPTI N/A
  • AVG Volume (30 Days)
  • BCAB 1.6M
  • MPTI 33.0K
  • Earning Date
  • BCAB 11-08-2024
  • MPTI 11-07-2024
  • Dividend Yield
  • BCAB N/A
  • MPTI N/A
  • EPS Growth
  • BCAB N/A
  • MPTI 87.47
  • EPS
  • BCAB N/A
  • MPTI 1.76
  • Revenue
  • BCAB N/A
  • MPTI $44,654,000.00
  • Revenue This Year
  • BCAB N/A
  • MPTI $18.43
  • Revenue Next Year
  • BCAB N/A
  • MPTI $8.16
  • P/E Ratio
  • BCAB N/A
  • MPTI $30.37
  • Revenue Growth
  • BCAB N/A
  • MPTI 22.02
  • 52 Week Low
  • BCAB $1.14
  • MPTI $21.04
  • 52 Week High
  • BCAB $4.02
  • MPTI $54.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 55.80
  • MPTI 70.52
  • Support Level
  • BCAB $1.87
  • MPTI $48.47
  • Resistance Level
  • BCAB $2.13
  • MPTI $54.00
  • Average True Range (ATR)
  • BCAB 0.12
  • MPTI 2.91
  • MACD
  • BCAB 0.00
  • MPTI -0.04
  • Stochastic Oscillator
  • BCAB 68.90
  • MPTI 83.43

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About MPTI M-tron Industries Inc.

M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.

Share on Social Networks: